Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1078-1080, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gourlain, H.
Right arrow Articles by Levillain, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gourlain, H.
Right arrow Articles by Levillain, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Hematology
(Clinical Chemistry. 1997;43:1078-1080.)
© 1997 American Association for Clinical Chemistry, Inc.


Technical Briefs

Interference of Methylene Blue with CO-Oximetry of Hemoglobin Derivatives

Hervé Gourlain1,a, Françoise Buneaux1, Stephen W. Borron2, Bernard Gouget3 and Pierre Levillain1

1 Lab. de Toxicol., and
2 Réanimation Toxicol., Hôpital Fernand Widal, 200 rue du Fg-St-Denis, 75475 Paris Cedex 10, France;
3 C.N.E.H., 9 rue Antoine Chantin, 75014 Paris, France;
a author for correspondence: fax +33 1 40 05 48 78

Methylene blue (MB) is frequently used as an antidote in treating methemoglobinemia (1) because it facilitates the reducing activity of the NADPH-dependent methemoglobin reductase system in erythrocytes (2). However, MB absorbs strongly between 550 and 700 nm (Fig. 1 ), the same spectrophotometric region as that of the various hemoglobin derivatives: oxyhemoglobin (O2Hb), deoxyhemoglobin (HHb), methemoglobin (MetHb), and carboxyhemoglobin (COHb). To evaluate the potential magnitude and direction of errors linked to the presence of MB for the results for total hemoglobin (tHb) and its derivatives, we evaluated six CO-Oximeters. The wavelengths used by each instrument for these determinations are as follows: IL 482 (Instrumentation Laboratory, Lexington, MA), 535, 585.2, 594.5, and 626.6 nm; CCD 270 (Chiron Diagnostics, Medfield, MA), 557, 577, 597, 605, 624, 635, and 650 nm; CCD 835 (Chiron; wavelengths not communicated); OSM3 (Radiometer, Copenhagen, Denmark), 535, 560, 577, 622, 636, and 670 nm; ABL 520 (Radiometer; same wavelengths as OSM3); AVL 912 (AVL Scientific Corp., Roswell, GA), 530, 536, 542, 548, 554, 560, 566, 572, 578, 584, 590, 604, 612, 622, 630, 640, and 648 nm.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1. Spectra of hemoglobin derivatives and methylene blue.

The absorbance of MB in physiological (isotonic) saline solution peaks at 663 nm.

Blood was collected from five healthy volunteers with informed consent. Because the study involved only blood sampling, Institutional Ethics Committee Review was not required in France. The five samples were combined to obtain 120 mL of pooled blood, which were then separated into three 40-mL fractions:

–Fraction N, which had no enrichment in CO or MetHb.

–Fraction CO, which was enriched in CO by tonometry with use of an IL 237 tonometer (Instrumentation Laboratory) and CO in nitrogen, 10 mL/L (Société Cosma, Igny 91430, France). Because . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
B. H. A. Maas, A. Buursma, R. A. J. Ernst, A. H. J. Maas, and W. G. Zijlstra
Lyophilized bovine hemoglobin as a possible reference material for the determination of hemoglobin derivatives in human blood
Clin. Chem., November 1, 1998; 44(11): 2331 - 2339.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.